ARCHIVES

After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA

This article is from The Cancer Letter archive.

Vol. 21 No. 15 | April 14, 1995

Download PDF Visit The Full Archive

Related Articles

ASCO Guideline Aims To Improve Hormone Receptor Testing

April 23, 2010

In Brief: AACR Voted On Naming Delegates To Congress, Not On Attending; ACCC Membership Over 300

February 17, 1978

ASCO Releases Abstracts To 25,000, But Adds Warning On Stock Trading

April 19, 2002

Intergroup 5-FU/Levamisole Study Positive Enough Now To End Untreated Control Arms

September 22, 1989

Nominations Open for Bristol-Myers $25,000

September 29, 1978

ECOG Subcontractors Critique Cancer Control Program

August 24, 1979